MESOTHELIOMA
Clinical trials for MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new MESOTHELIOMA trials appear
Sign up with your email to follow new studies for MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug access extended for cancer patients who responded well
Disease control CompletedThis study offers continued access to the drug tazemetostat for 58 people with certain cancers who previously benefited from it in other trials. The main goal is to track long-term safety and how long participants stay on the drug. It is not a cure but helps control the disease.
Matched conditions: MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: Epizyme, Inc. • Aim: Disease control
Last updated May 17, 2026 04:29 UTC
-
New drug combo shows promise in early tumor trial
Disease control CompletedThis early-stage study tested a combination of a radioactive drug (177Lu-DOTA-TATE) and a targeted pill (olaparib) in 18 adults with certain tumors that have a specific marker. The goal was to find the safest dose and understand side effects. This approach aims to make tumor cell…
Matched conditions: MESOTHELIOMA
Phase: PHASE1 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated May 17, 2026 04:18 UTC
-
Immunotherapy boosts chemo in tough lung cancer trial
Disease control CompletedThis study tested adding the immunotherapy drug durvalumab to standard chemotherapy for people with advanced pleural mesothelioma that cannot be removed by surgery. The goal was to see if the combination helps patients live longer. About 214 adults took part, receiving either the…
Matched conditions: MESOTHELIOMA
Phase: PHASE3 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New chemo delivery method shows promise for rare lung cancer
Disease control CompletedThis study tested a way to deliver strong chemotherapy drugs directly to the tumor in people with a rare lung cancer called malignant pleural mesothelioma that cannot be removed by surgery. The treatment, called transarterial chemoperfusion, uses a catheter to send cisplatin, met…
Matched conditions: MESOTHELIOMA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for patients whose cancers resist immunotherapy
Disease control CompletedThis early-stage study tested an experimental drug called CTX-471, given alone or with another immunotherapy (pembrolizumab), in 100 adults with advanced solid tumors that had stopped responding to standard PD-1/PD-L1 inhibitors. The main goal was to check safety and find the rig…
Matched conditions: MESOTHELIOMA
Phase: PHASE1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New test could help doctors pick the right cancer therapy faster
Knowledge-focused CompletedThis study tested a new method called the mass response biomarker to see if it can predict how well a cancer patient will respond to specific treatments. Researchers collected tumor cells from 72 adults with various cancers using fluid samples or tissue biopsies. The goal was to …
Matched conditions: MESOTHELIOMA
Sponsor: Travera Inc • Aim: Knowledge-focused
Last updated May 17, 2026 04:13 UTC